Persistent hypogammaglobulinemia due to immunoglobulin class switch impairment by peri-transplant rituximab therapyKentaro Mizuhara, Yoshinobu Maeda, Yuichi Sumii et al.|International Journal of Hematology|2020Cited by 6
Allogeneic hematopoietic stem cell transplantation in a prior lung transplant recipientYuki Fujiwara, Yoshinobu Maeda, Ken‐ichi Matsuoka et al.|International Journal of Hematology|2020Cited by 1
Total body irradiation-based haploidentical hematopoietic stem cell transplantation using posttransplant cyclophosphamide after administration of inotuzumab ozogamicin: A case reportMasaya Abe, Yoshinobu Maeda, Nobuharu Fujii et al.|Leukemia Research Reports|2021Cited by 0
Efficacy and relapse profiles of Pola‐R‐ <scp>CHP</scp> versus R‐ <scp>CHOP</scp> in previously untreated diffuse large B‐cell lymphoma: A multicentre real‐world studyToshiki Terao, Yoshinobu Maeda, Isao Yoshida et al.|British Journal of Haematology|2025Cited by 0
WT1 mRNA in peripheral blood enables early prognostic stratification in AML patients receiving venetoclax and azacitidine therapyHiroyuki Sugiura, Yoshinobu Maeda, Noboru Asada et al.|Annals of Hematology|2026Cited by 0